1. Home
  2. CRON vs BTX Comparison

CRON vs BTX Comparison

Compare CRON & BTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRON
  • BTX
  • Stock Information
  • Founded
  • CRON N/A
  • BTX N/A
  • Country
  • CRON Canada
  • BTX United States
  • Employees
  • CRON N/A
  • BTX N/A
  • Industry
  • CRON Medicinal Chemicals and Botanical Products
  • BTX
  • Sector
  • CRON Health Care
  • BTX
  • Exchange
  • CRON Nasdaq
  • BTX Nasdaq
  • Market Cap
  • CRON 809.4M
  • BTX 769.1M
  • IPO Year
  • CRON N/A
  • BTX N/A
  • Fundamental
  • Price
  • CRON $2.49
  • BTX $6.84
  • Analyst Decision
  • CRON
  • BTX
  • Analyst Count
  • CRON 0
  • BTX 0
  • Target Price
  • CRON N/A
  • BTX N/A
  • AVG Volume (30 Days)
  • CRON 2.0M
  • BTX 988.7K
  • Earning Date
  • CRON 11-06-2025
  • BTX 11-01-2025
  • Dividend Yield
  • CRON N/A
  • BTX 14.45%
  • EPS Growth
  • CRON N/A
  • BTX N/A
  • EPS
  • CRON 0.05
  • BTX N/A
  • Revenue
  • CRON $130,282,000.00
  • BTX N/A
  • Revenue This Year
  • CRON $19.67
  • BTX N/A
  • Revenue Next Year
  • CRON $30.56
  • BTX N/A
  • P/E Ratio
  • CRON $51.19
  • BTX N/A
  • Revenue Growth
  • CRON 28.01
  • BTX N/A
  • 52 Week Low
  • CRON $1.60
  • BTX $5.10
  • 52 Week High
  • CRON $3.16
  • BTX $8.31
  • Technical
  • Relative Strength Index (RSI)
  • CRON 47.74
  • BTX 53.28
  • Support Level
  • CRON $2.44
  • BTX $6.49
  • Resistance Level
  • CRON $2.57
  • BTX $6.64
  • Average True Range (ATR)
  • CRON 0.10
  • BTX 0.12
  • MACD
  • CRON -0.02
  • BTX 0.03
  • Stochastic Oscillator
  • CRON 19.48
  • BTX 76.34

About CRON Cronos Group Inc. Common Share

Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

About BTX BlackRock Technology and Private Equity Term Trust Common Shares of Beneficial Interest

BlackRock Technology and Private Equity Term Trust objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust will invest in equity securities issued by mid - and small capitalization companies that the Trust's adviser believes have above-average earnings growth potential.

Share on Social Networks: